Clinical predictors of marked improvement in left ventricular performance after cardiac resynchronization therapy in

Maurizio Mangiavacchi1, Maurizio Gasparini, Francesco Faletra

  • 1Department of Cardiology, IRCCS Istituto Clinico Humanitas, Rozzano, Milan, Italy. maurizio.mangiavacchi@humanitas.it

American Heart Journal
|January 31, 2006
PubMed

Insights

Cardiac resynchronization therapy (CRT) improves heart function and exercise capacity. Nonischemic heart failure etiology is the key predictor of a significant positive response to CRT.

Area of Science:

  • Cardiology
  • Medical Devices
  • Heart Failure Management

Background:

  • Cardiac resynchronization therapy (CRT) is known to improve cardiac performance and reduce mortality.
  • Identifying patients who will most benefit from CRT remains a clinical challenge.
  • Predictive factors for optimal CRT outcomes require further elucidation.

Purpose of the Study:

  • To identify pre-implantation characteristics that predict the best outcomes following CRT.
  • To determine which patient subgroups experience the most significant benefits from CRT.

Main Methods:

  • Observational study involving 156 patients undergoing CRT.
  • Echocardiography and 6-minute walking tests were performed at baseline and 12 months post-CRT.
  • Analysis of pre-implant characteristics to correlate with post-CRT outcomes.

Main Results:

  • Significant improvements observed post-CRT: increased left ventricular ejection fraction (+29.6%), decreased end-systolic volume (-26.4%), reduced mitral regurgitation, and improved NYHA functional class.
  • Exercise tolerance increased by 31.1% post-CRT.
  • Nonischemic etiology of heart failure was the sole independent predictor of a marked increase in left ventricular ejection fraction; benefit inversely correlated with ischemic damage extent in ischemic cardiomyopathy.

Conclusions:

  • CRT leads to long-term improvements in left ventricular function and exercise tolerance.
  • Nonischemic cardiomyopathy etiology is the strongest predictor of a marked CRT response.
  • Absence of nonviable scar tissue in nonischemic hearts likely contributes to better CRT outcomes.
Abstract

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
273
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
516
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
768
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
720
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
603
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.0K